Abeona Therapeutics Inc. (ABEO)
Market Closed
1 Sep, 20:00
$
5. 98
+0.13
+2.2222%
After Hours
$
+0.02 +0.3344% 6. 00
344.25M Market Cap
- P/E Ratio
593% Div Yield
682,980 Volume
-2.23 Eps
$ 5.85
Previous Close 
Want to track ABEO and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Abeona Therapeutics Inc. (ABEO) Statistics
Valuation metrics
Market Cap 344.25M
Enterprise value 301.05M
Trailing P/E (ttm) -5.21
Forward P/E 19.26
PEG ratio 0.02
Price/Sales (ttm) 13.22
Price/Book (mrq) 2.64
Enterprise Value/Revenue 11.8
Enterprise Value/EBITDA -4.21
Overview
Shares outstanding 56.87M
Float 36.34M
Shares short 16.49M
% Held by insiders 0.17%
% Held by institutions 0.71%
Average volume (10 days) 1.07M
Average volume (90 days) 1.36M
Price summary
52-Week low 4
52-Week high 7.65
Beta 1.34
50-Day moving average 6.52
200-Day moving average 5.46
Dividends and splits
Forward annual dividend rate -
Forward annual dividend yield -
Trailing annual dividend rate -
Trailing annual dividend yield -
5-Year annual dividend yield -
Payout ratio -
Dividend Date -
Ex-Dividend Date -
Last split factor 1:25
Last split Date 5 Jul 2022
Financials
Fiscal year
Fiscal year ends 31 Dec 2025
Most recent quarter (mrq) 31 Mar 2026
Profitability
Profit margin -2.46%
Operating margin -3.28%
Operational effectiveness
Return on assets -0.35%
Return on equity -0.42%
Income Statement
Revenue (ttm) 14.54M
Revenue per share (ttm) 0.45
Quarterly revenue growth (yoy) 0.61%
Gross profit (ttm) -18.01M
EBITDA 72.45M
Net income to common (ttm) 66.14M
Diluted EPS (ttm) -1.1
Quarterly earnings growth (yoy) -
Balance Sheet
Total cash (mrq) 168.27M
Total cash per share (mrq) 2.57
Total debt (mrq) 23.17M
Total Debt/Equity (mrq) 0.16
Current ratio (mrq) 6.63%
Book value per share (mrq) 2.24
Cash Flow
Cash flow statement -77.73M
Levered free cash flow (LFCF) -56.59M
